600
Participants
Start Date
January 6, 2018
Primary Completion Date
December 31, 2021
Study Completion Date
March 31, 2023
cancer patients
Blood sample RNA\_seq at time of diagnostic, best response and relapse ; Biopsy Exom\_seq and RNA\_seq at time of diagnostic and relapse Immulogical Profiling at time of diagnostic, best response and relapse
RECRUITING
Institut Paoli Calmettes, Marseille
RECRUITING
CGFL, Dijon
RECRUITING
Chu Dijon Bourgogne, Dijon
NOT_YET_RECRUITING
Chu de Besancon, Besançon
RECRUITING
Institut Godinot, Reims
NOT_YET_RECRUITING
Institut de Cancerologie de Lorraine, Nancy
RECRUITING
Hopitaux Universitaires de Strasbourg, Strasbourg
RECRUITING
Centre Leon Berard, Lyon
RECRUITING
Institut Curie, Paris
RECRUITING
Chu de Poitiers, Poitiers
RECRUITING
APHP - Hôpital Beaujon, Clichy
Lead Sponsor
Oncodesign SA
INDUSTRY